Chief Business Officer at evitria
Mail:
ds@evitria.com
Location:
London, Great Britain
Articles written by Desmond Schofield (54)
-
Monoclonal antibody drugs for cancer
MAbs have proven to be an effective treatment option for many patients suffering from cancer. Get more details on these innovative drugs in this article.

-
Critical steps in monoclonal antibody development
In the development of monoclonal antibodies, there are several difficulties to overcome. Read more about them in this article!

-
Manufacturers of monoclonal antibodies
Monoclonal antibodies have a wide fields of application, but who produces them? Discover some mAbs producers in this article!

-
What are disadvantages of monoclonal antibodies?
Monoclonal antibodies come with unique advantages – but also some downsides. Read more on the disadvantages of mAbs in this article.

-
Advantages of monoclonal antibodies in an overview
Monoclonal antibodies have a variety of different fields of application, due to some unique properties – let’s discover their advantages in this article!

-
What is a monoclonal antibody?
Not only in recent years, monoclonal antibodies have grown in public attention. But what is a monoclonal antibody, actually?

-
Bispecific Antibodies: Commercial Successes and Research Feasibility
In the past 10 years, the use of bispecific antibodies – proteins capable of engaging two targets simultaneously – has become a key focus area for the industry. Read all about their success and research feasibility in this article.

-
True Fc Silencing Technology: STR from mAbsolve
Therapeutic antibodies can be split into two broad families: those which enhance cell killing by activation of the host’s immune system, and those which block an interaction or neutralize a pathway. Read more about the benefits of sourcing STR-silenced antibodies through evitria!

-
Fc Silenced Antibody – Therapeutic antibodies with reduced side effect profile
One of the most exciting recent developments in the sector is the engineering of antibodies’ fragment crystallizable (Fc region). Fc engineering entails the optimization of recombinant monoclonal antibodies, anticancer bispecific antibodies and Fc fusion proteins by means of modifications at specific residues to enhance performance in their intended applications. Read more!

-
Antibody glycoengineering: pushing forward biotechnology
The importance of glycosylation patterns (sugar sequences) on proteins and their glycobiology have been intensely investigated in recent years, and the deeper understanding spawned novel applications that push biotechnology forward. vice offerings in the field of glyco-engineering.
